";s:4:"text";s:4165:" Ali M, Khan FA. A primary goal of pain management after major surgery is for you to awaken relatively comfortable and to experience an uninterrupted transition to pain control, but some discomfort is common and should be anticipated after surgery. While opioid therapy remains the mainstay of therapy for postsurgical pain, opioids have undesired side effects including delayed recovery of bowel function, respiratory depression, and postoperative nausea and vomiting. The use of other analgesics aside from those involved in the study, such as opioids, tranquilizers, anesthetics and antiemetics, were prohibited during the study period. The skin of your back will be cleaned with a sterile solution and numbed with a local anesthetic. By using this website, you agree to our eCollection 2020.Liu X, Song T, Chen X, Zhang J, Shan C, Chang L, Xu H.BMC Anesthesiol. Its plasma half-life is 5 h, and in clinical studies the duration of analgesic activity ranges from 3 to 6 h [In the present study, the VAS at rest at timepoints TThe incidence of adverse reactions associated with nalbuphine is relatively low compared with other opioid medications. 2020 Mar;36(3):219-226. doi: 10.1097/AJP.0000000000000792.BMC Anesthesiol. Pain control following surgery is a priority for both you and your doctors. Group E experienced significantly longer duration of analgesia compared with group C. At each timepoint, the vital signs (SBP, DBP, respiratory rate, and heart rate) of the 2 groups were statistically comparable. The study was blinded, by excluding the researcher who prepared the postoperative medications from participating in test observations and follow-ups. This may result in fewer side effects, such as nausea, vomiting, itching, and drowsiness.In some cases, a nerve block can be used as the main anesthetic for your surgery. Headache can occur, but this is rare. Therefore, there is a higher demand for anesthesia and a need to improve the quality of analgesics. However, the present results warrant further experiments to determine comprehensively the effectiveness and safety of nalbuphine for the treatment of pain after ambulatory surgery.This study indicates that nalbuphine at a recommended dose of 0.2 mg/kg is safe and effective for pain management after ambulatory surgery.The datasets generated and analyzed during the present study are available from the corresponding author on reasonable request.Shirakami G, Teratani Y, Namba T, Hirakata H, Tazuke-Nishimura M, Fukuda K. Delayed discharge and acceptability of ambulatory surgery in adult outpatients receiving general anesthesia. Patients with current or histories of any of the following were also excluded: opioid allergy; acute or chronic alcoholism or drug addiction; neurological disease; opioid used within the last 3 months; paralytic ileus; increased intracranial pressure or head injury; chronic opioid use (taking opioids for more than 3 months); hypotension; hypothyroidism, asthma (to be avoided during seizure); hypertrophy of the prostate; epilepsy; coronary heart disease; bronchial asthma; respiratory insufficiency; or respiratory failure. Anesth Analg.